Acquired methemoglobinemia revisited.
Identifieur interne : 000348 ( Main/Exploration ); précédent : 000347; suivant : 000349Acquired methemoglobinemia revisited.
Auteurs : Larry Trapp [États-Unis] ; John WillSource :
- Dental clinics of North America [ 1558-0512 ] ; 2010.
Descripteurs français
- KwdFr :
- Anesthésie dentaire (effets indésirables), Anesthésie dentaire (méthodes), Anesthésiques combinés (effets indésirables), Anesthésiques locaux (effets indésirables), Antienzymes (usage thérapeutique), Association de lidocaïne et de prilocaïne (MeSH), Benzocaïne (administration et posologie), Benzocaïne (effets indésirables), Bleu de méthylène (usage thérapeutique), Humains (MeSH), Hémoglobines (métabolisme), Lidocaïne (effets indésirables), Méthémoglobine (métabolisme), Méthémoglobinémie (diagnostic), Méthémoglobinémie (induit chimiquement), Méthémoglobinémie (métabolisme), Méthémoglobinémie (traitement médicamenteux), Oxydoréduction (MeSH), Oxymétrie (MeSH), Prilocaïne (administration et posologie), Prilocaïne (effets indésirables), Protoxyde d'azote (effets indésirables).
- MESH :
- administration et posologie : Benzocaïne, Prilocaïne.
- diagnostic : Méthémoglobinémie.
- effets indésirables : Anesthésie dentaire, Anesthésiques combinés, Anesthésiques locaux, Benzocaïne, Lidocaïne, Prilocaïne, Protoxyde d'azote.
- induit chimiquement : Méthémoglobinémie.
- métabolisme : Hémoglobines, Méthémoglobine, Méthémoglobinémie.
- méthodes : Anesthésie dentaire.
- traitement médicamenteux : Méthémoglobinémie.
- usage thérapeutique : Antienzymes, Bleu de méthylène.
- Association de lidocaïne et de prilocaïne, Humains, Oxydoréduction, Oxymétrie.
English descriptors
- KwdEn :
- Anesthesia, Dental (adverse effects), Anesthesia, Dental (methods), Anesthetics, Combined (adverse effects), Anesthetics, Local (adverse effects), Benzocaine (administration & dosage), Benzocaine (adverse effects), Enzyme Inhibitors (therapeutic use), Hemoglobins (metabolism), Humans (MeSH), Lidocaine (adverse effects), Lidocaine, Prilocaine Drug Combination (MeSH), Methemoglobin (metabolism), Methemoglobinemia (chemically induced), Methemoglobinemia (diagnosis), Methemoglobinemia (drug therapy), Methemoglobinemia (metabolism), Methylene Blue (therapeutic use), Nitrous Oxide (adverse effects), Oxidation-Reduction (MeSH), Oximetry (MeSH), Prilocaine (administration & dosage), Prilocaine (adverse effects).
- MESH :
- chemical , administration & dosage : Benzocaine, Prilocaine.
- chemical , adverse effects : Anesthetics, Combined, Anesthetics, Local, Benzocaine, Lidocaine, Nitrous Oxide, Prilocaine.
- adverse effects : Anesthesia, Dental.
- chemically induced : Methemoglobinemia.
- diagnosis : Methemoglobinemia.
- drug therapy : Methemoglobinemia.
- chemical , metabolism : Hemoglobins, Methemoglobin, Methemoglobinemia.
- methods : Anesthesia, Dental.
- chemical , therapeutic use : Enzyme Inhibitors, Methylene Blue.
- Humans, Lidocaine, Prilocaine Drug Combination, Oxidation-Reduction, Oximetry.
Abstract
Dentistry has two medications in its pain management armamentarium that may cause the potentially life-threatening disorder methemoglobinemia. The first medications are the topical local anesthetics benzocaine and prilocaine. The second medication is the injectable local anesthetic prilocaine. Acquired methemoglobinemia remains a source of morbidity and mortality in dental and medical patients despite the fact that it is better understood now than it was even a decade ago. It is in the interest of all dental patients that their treating dentists review this disorder. The safety of dental patients mandates professional awareness.
DOI: 10.1016/j.cden.2010.06.007
PubMed: 20831930
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acquired methemoglobinemia revisited.</title><author><name sortKey="Trapp, Larry" sort="Trapp, Larry" uniqKey="Trapp L" first="Larry" last="Trapp">Larry Trapp</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dental Anesthesiology, Loma Linda University School of Dentistry, Loma Linda, CA 92350, USA. ltrapp@llu.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dental Anesthesiology, Loma Linda University School of Dentistry, Loma Linda, CA 92350</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Will, John" sort="Will, John" uniqKey="Will J" first="John" last="Will">John Will</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20831930</idno><idno type="pmid">20831930</idno><idno type="doi">10.1016/j.cden.2010.06.007</idno><idno type="wicri:Area/Main/Corpus">000333</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000333</idno><idno type="wicri:Area/Main/Curation">000333</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000333</idno><idno type="wicri:Area/Main/Exploration">000333</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Acquired methemoglobinemia revisited.</title><author><name sortKey="Trapp, Larry" sort="Trapp, Larry" uniqKey="Trapp L" first="Larry" last="Trapp">Larry Trapp</name><affiliation wicri:level="2"><nlm:affiliation>Department of Dental Anesthesiology, Loma Linda University School of Dentistry, Loma Linda, CA 92350, USA. ltrapp@llu.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Dental Anesthesiology, Loma Linda University School of Dentistry, Loma Linda, CA 92350</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Will, John" sort="Will, John" uniqKey="Will J" first="John" last="Will">John Will</name></author></analytic><series><title level="j">Dental clinics of North America</title><idno type="eISSN">1558-0512</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anesthesia, Dental (adverse effects)</term><term>Anesthesia, Dental (methods)</term><term>Anesthetics, Combined (adverse effects)</term><term>Anesthetics, Local (adverse effects)</term><term>Benzocaine (administration & dosage)</term><term>Benzocaine (adverse effects)</term><term>Enzyme Inhibitors (therapeutic use)</term><term>Hemoglobins (metabolism)</term><term>Humans (MeSH)</term><term>Lidocaine (adverse effects)</term><term>Lidocaine, Prilocaine Drug Combination (MeSH)</term><term>Methemoglobin (metabolism)</term><term>Methemoglobinemia (chemically induced)</term><term>Methemoglobinemia (diagnosis)</term><term>Methemoglobinemia (drug therapy)</term><term>Methemoglobinemia (metabolism)</term><term>Methylene Blue (therapeutic use)</term><term>Nitrous Oxide (adverse effects)</term><term>Oxidation-Reduction (MeSH)</term><term>Oximetry (MeSH)</term><term>Prilocaine (administration & dosage)</term><term>Prilocaine (adverse effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anesthésie dentaire (effets indésirables)</term><term>Anesthésie dentaire (méthodes)</term><term>Anesthésiques combinés (effets indésirables)</term><term>Anesthésiques locaux (effets indésirables)</term><term>Antienzymes (usage thérapeutique)</term><term>Association de lidocaïne et de prilocaïne (MeSH)</term><term>Benzocaïne (administration et posologie)</term><term>Benzocaïne (effets indésirables)</term><term>Bleu de méthylène (usage thérapeutique)</term><term>Humains (MeSH)</term><term>Hémoglobines (métabolisme)</term><term>Lidocaïne (effets indésirables)</term><term>Méthémoglobine (métabolisme)</term><term>Méthémoglobinémie (diagnostic)</term><term>Méthémoglobinémie (induit chimiquement)</term><term>Méthémoglobinémie (métabolisme)</term><term>Méthémoglobinémie (traitement médicamenteux)</term><term>Oxydoréduction (MeSH)</term><term>Oxymétrie (MeSH)</term><term>Prilocaïne (administration et posologie)</term><term>Prilocaïne (effets indésirables)</term><term>Protoxyde d'azote (effets indésirables)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Benzocaine</term><term>Prilocaine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anesthetics, Combined</term><term>Anesthetics, Local</term><term>Benzocaine</term><term>Lidocaine</term><term>Nitrous Oxide</term><term>Prilocaine</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Benzocaïne</term><term>Prilocaïne</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Anesthesia, Dental</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Methemoglobinemia</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Methemoglobinemia</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Méthémoglobinémie</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Methemoglobinemia</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anesthésie dentaire</term><term>Anesthésiques combinés</term><term>Anesthésiques locaux</term><term>Benzocaïne</term><term>Lidocaïne</term><term>Prilocaïne</term><term>Protoxyde d'azote</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Méthémoglobinémie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Hemoglobins</term><term>Methemoglobin</term><term>Methemoglobinemia</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Anesthesia, Dental</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Hémoglobines</term><term>Méthémoglobine</term><term>Méthémoglobinémie</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Anesthésie dentaire</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Enzyme Inhibitors</term><term>Methylene Blue</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Méthémoglobinémie</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antienzymes</term><term>Bleu de méthylène</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Lidocaine, Prilocaine Drug Combination</term><term>Oxidation-Reduction</term><term>Oximetry</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association de lidocaïne et de prilocaïne</term><term>Humains</term><term>Oxydoréduction</term><term>Oxymétrie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Dentistry has two medications in its pain management armamentarium that may cause the potentially life-threatening disorder methemoglobinemia. The first medications are the topical local anesthetics benzocaine and prilocaine. The second medication is the injectable local anesthetic prilocaine. Acquired methemoglobinemia remains a source of morbidity and mortality in dental and medical patients despite the fact that it is better understood now than it was even a decade ago. It is in the interest of all dental patients that their treating dentists review this disorder. The safety of dental patients mandates professional awareness.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20831930</PMID><DateCompleted><Year>2010</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-0512</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Dental clinics of North America</Title><ISOAbbreviation>Dent Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Acquired methemoglobinemia revisited.</ArticleTitle><Pagination><MedlinePgn>665-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cden.2010.06.007</ELocationID><Abstract><AbstractText>Dentistry has two medications in its pain management armamentarium that may cause the potentially life-threatening disorder methemoglobinemia. The first medications are the topical local anesthetics benzocaine and prilocaine. The second medication is the injectable local anesthetic prilocaine. Acquired methemoglobinemia remains a source of morbidity and mortality in dental and medical patients despite the fact that it is better understood now than it was even a decade ago. It is in the interest of all dental patients that their treating dentists review this disorder. The safety of dental patients mandates professional awareness.</AbstractText><CopyrightInformation>Copyright © 2010 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trapp</LastName><ForeName>Larry</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Dental Anesthesiology, Loma Linda University School of Dentistry, Loma Linda, CA 92350, USA. ltrapp@llu.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Will</LastName><ForeName>John</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dent Clin North Am</MedlineTA><NlmUniqueID>0217440</NlmUniqueID><ISSNLinking>0011-8532</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019162">Anesthetics, Combined</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077442">Lidocaine, Prilocaine Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>046O35D44R</RegistryNumber><NameOfSubstance UI="D011318">Prilocaine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-37-1</RegistryNumber><NameOfSubstance UI="D008706">Methemoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical><Chemical><RegistryNumber>K50XQU1029</RegistryNumber><NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>T42P99266K</RegistryNumber><NameOfSubstance UI="D008751">Methylene Blue</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3RSY48JW5</RegistryNumber><NameOfSubstance UI="D001566">Benzocaine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000766" MajorTopicYN="N">Anesthesia, Dental</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019162" MajorTopicYN="N">Anesthetics, Combined</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001566" MajorTopicYN="N">Benzocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="N">Lidocaine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077442" MajorTopicYN="N">Lidocaine, Prilocaine Drug Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008706" MajorTopicYN="N">Methemoglobin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008708" MajorTopicYN="N">Methemoglobinemia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008751" MajorTopicYN="N">Methylene Blue</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009609" MajorTopicYN="N">Nitrous Oxide</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="N">Oximetry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011318" MajorTopicYN="N">Prilocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20831930</ArticleId><ArticleId IdType="pii">S0011-8532(10)00065-0</ArticleId><ArticleId IdType="doi">10.1016/j.cden.2010.06.007</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><noCountry><name sortKey="Will, John" sort="Will, John" uniqKey="Will J" first="John" last="Will">John Will</name></noCountry><country name="États-Unis"><region name="Californie"><name sortKey="Trapp, Larry" sort="Trapp, Larry" uniqKey="Trapp L" first="Larry" last="Trapp">Larry Trapp</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000348 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000348 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20831930
|texte= Acquired methemoglobinemia revisited.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20831930" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |